Peritoneal carcinomatosis (PC) is a common evolution of cancer of the gastrointestinal tract, and has been traditionally regarded as a terminal disease with short median survival. During the last 20 years, due to its favourable oncologic results, a new loco-regional therapeutic approach, combining cytoreductive surgery with intra-operative intraperitoneal chemotherapy has achieved an important development. After liver metastatic disease, peritoneal carcinomatosis is the second most frequent cause of death in colorectal cancer patient is defined as a stage IV tumour which prognosis is the worst. The extent of peritoneal carcinomatosis is, however, difficult for assessment preoperatively, and precise evaluation is most often performed during surgical exploration. Cytoreductive surgery associated with chemotherapy for the treatment of peritoneal carcinomatosis should be performed in young patients with limited and resectable carcinomatosis, in specialized institutions involved in the management of peritoneal surface malignancies.
Dawson LE, Russell AH, Tong D, Wisbeck WM. AdenoWJGO|www.wjgnet.com Colorectal carcinomatosis February 15, 2010|Volume 2|Issue 2|carcinoma of the sigmoid colon: sites of initial dis¬semination and clinical patterns of recurrence follow¬ing surgery alone. JSurg Oncol 1983; 22: 95-99
Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-367
Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Franfois Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363
Koppe MJ, Boer man OC, Oyen WJ, Bleichr odt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243:212-222
Glehen O, Osinsky D, Beaujard AC, Gilly F N. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin N Am 2003; 12: 729-739, xiii
Esquivel J, Elias D, Baratti D, Kusamura S, Deraco M. Consensus statement on the loco re-gional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008; 98: 263-267
Confuorto G, Giuliano ME, Grimaldi A, Viviano C. Peritoneal carcinomatosis from colorectal cancer: HIPEC? Surg Oncol 2007; 16 Suppl 1: S149-S152
Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoe tmul der F A . Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37: 979-984
Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743.
Meigs JV. Tumours of the female pelvic organs. New York: Macmillan, 1935.
Munnell EW. The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961. Am J Obstet Gynecol 1968; 100:790-805.
Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101-104.
Spratt JS, Adcock RA, Sherrill W, Travathen S. Hyperthermic peritoneal perfusion system in ca¬nines. Cancer Res 1980; 40: 253-255.
Sugarbaker PH. Management of perit oneal-surf ace malignancy: the surgeon's role. Langenbecks Arch Surg 1999; 384:576-587
Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989; 27: 621-627.
Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 1998; 41: 147-154.
Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 Suppl: S15-S25.
Di Carlo I, Pulvirenti E, Sparatore F, Toro A, Cordio S. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects. Surg Oncol 2007; 16 Suppl 1: S145-S148
Elias D, Raynard B, Rouquie D, Ciuchendea R, Pocard M, Ducreux M. Peritoneal carcinomatosis of colorectal origin. Gastroenterol Clin Biol 2006; 30:1200-1204
Email this article (Login required) 
